They found a NRAS mutation in 11 oligodendrogliomas, 2 KRAS mutations in 16 anaplastic oligodendrogliomas, and 2 KRAS mutations and 2 NRAS mutations in 226 glioblastomas. This evidence concerns the gene NRAS and oligodendroglioma.